Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

4 guidelines target cardiovascular disease prevention

The American College of Cardiology (ACC) and the American Heart Association (AHA) released four prevention guidelines to reduce the risk of cardiovascular disease. The 2013 joint guidelines focus on cardiovascular risk assessment, lifestyle management, cholesterol treatment and managing overweight and obese adults.

ACE inhibitor/ARB combo risky in patients with diabetic nephropathy

Using ACE inhibitors along with ARBs increased the risk of adverse events in patients with diabetic nephropathy in a study published online Nov. 9 in the New England Journal of Medicine. Investigators stopped the study early due to safety concerns.

Low infant weight increases risk of cardiac cath complications

Cardiac catheterization becomes more risky with lower infant birth weights, according to a study published in the Nov. 1 issue of Catheterization and Cardiovascular Interventions. The risk is significantly higher in infants weighing less than 2 kilograms.

Metformin may not offer cardiovascular benefits

Although research has suggested some cardiovascular benefit to the glucose-lowering drug metformin, a study published online Nov. 7 in The Lancet found that the drug had no effect on carotid intima-media thickness (cIMT) and little to no effect on other cardiovascular disease markers in patients who are at high risk for cardiovascular disease who take statins but do not have diabetes.

Calcium-channel blocker/clarithromycin combo increases risk for AKI hospitalization

Older adults who take calcium-channel blockers with clarithromycin are at higher risk for 30-day hospitalization for acute kidney injury (AKI) compared with the combination of calcium-channel blockers and azithromycin, a study published online Nov. 9 in JAMA found. 

LIA software proven to detect lead failures more frequently than impedance alone on Riata, Durata and Endotak leads

Medtronic, Inc. (NYSE:MDT) today announced FDA approval of its Lead Integrity Alert (LIA) software for use with non-Medtronic leads. Proprietary and exclusive software that resides in Medtronic defibrillators, LIA is now approved to report performance issues on Durata® and Riata® defibrillator leads (St. Jude Medical) and Endotak® (Boston Scientific) defibrillator leads when connected to a Medtronic device.

Veniti receives CE Mark approval for Vici Venous Stent

Veniti(TM), Inc. (Veniti), has received approval to CE Mark the Veniti Vici(TM) Venous Stent, specifically designed for the treatment of venous obstruction. In addition, the company received CE Mark approval for their varicose vein ablation product, the Veniti Veni(TM) RF Plus Ablation System. The CE Marks allow Veniti to sell products within the European Union.

Thumbnail

FDA gives food industry 60 days to chew the fat

In a move that may have the processed food industry blubbering, the FDA is attempting to require premarket approval for partially hydrogenated oils.

Displaying 7825 - 7832 of 10755

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.